A Judicial Panel on Multidistrict Litigation consolidated 13 insulin price-fixing lawsuits and future tag-along cases from states, counties and private entities against three of the largest pharmaceutical companies in the world, who face allegations of over-inflating prices of the insulin they manufacture.

Attorneys from two Florida firms are among the dozens of lawyers positioned to continue the litigation, which could have a far-reaching impact throughout the U.S., where more than 130 million adults are living with diabetes or prediabetes, according to the Centers for Disease Control and Prevention.